The Role of Glucose-6-Phosphatase in the Action of Insulin on Hepatic Glucose Production in the Rat

It has been suggested that regulation of glucose-6-phosphatase by insulin plays a role in the suppression of hepatic glucose production during feeding. We used hepatic glucose production (measured with the D-[3-3H]glucose infusion method) as an indicator of substrate flux through glucose-6-phosphatase in vivo. Compared with saline controls, insulin (7 mU · min−1 · kg−1, euglycemic clamp) suppressed hepatic glucose production virtually completely in both fasted (32.4 ± 2.4 vs. –6.1 ± 14 μmol · min−1 · kg−1) and fed (64.6 ± 6.4 vs. 5.5 ± 5.2 μmol · min−1 · kg−1) rats. Whereas hepatic glucose production was totally suppressed, [glucose-6-phosphate] in liver cytosol declined by only 27 and 35% in fasted and fed rats, respectively. Addition of hyperglycemia (10 mM) to the insulin infusion likewise fully suppressed hepatic glucose production (26.9 ± 1.4 vs. −9 ± 10 μmol · min−1 · kg−1 and 80.8 ± 10.1 vs. −3.6 ± 12.6 μmol · min−1 · kg−1 in fasted and fed rats, respectively), but [glucose-6-phosphate] again declined only modestly (21 and 27% in fasted and fed rats, respectively). This disproportionate suppression of hepatic glucose production could not be explained by cooperative substrate effects inasmuch as microsomal glucose-6-phosphatase isolated from saline- and insulin-treated rats followed Michaelis-Menten kinetics (Hill coefficient approximated 1). Acute insulin treatment of fasted rats in vivo did not reproducibly inhibit glucose-6-phosphatase activity assayed subsequently in isolated microsomes incubated in the absence of insulin. However, addition of insulin (0.6–600 nM) to either crude liver homogenates or to isolated, concentrated hepatic membranes (containing both microsomes and plasma membranes) inhibited glucose-6-phosphatase (P < 0.005 for each preparation). These findings indicate that inhibition of glucose-6-phosphatase is involved in the action of insulin to control hepatic glucose production.

[1]  G. Shulman,et al.  Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon. , 1978, The Journal of clinical investigation.

[2]  J. Radziuk Tracer methods and the metabolic disposal of a carbohydrate load in man. , 1987, Diabetes/metabolism reviews.

[3]  C. Ucla,et al.  Molecular cloning of glucokinase cDNA. Developmental and dietary regulation of glucokinase mRNA in rat liver. , 1987, The Journal of biological chemistry.

[4]  A. Sols,et al.  INSULIN-DEPENDENT SYNTHESIS OF LIVER GLUCOKINASE IN THE RAT. , 1963, Journal of Biological Chemistry.

[5]  F. Nuttall,et al.  Metabolic effects of oral glucose in the liver of fasted rats. , 1984, The American journal of physiology.

[6]  J. Wahren,et al.  Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load. , 1987, The Journal of clinical investigation.

[7]  F. Assimacopoulos-Jeannet,et al.  Inhibition of hepatic glucose production by insulin in vivo in rats: contribution of glycolysis. , 1986, The American journal of physiology.

[8]  A. Burchell Molecular pathology of glucose‐6‐phosphatase 1 , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[10]  L. Rossetti,et al.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. , 1992, The Journal of clinical investigation.

[11]  C. Newgard,et al.  Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? , 1983, The Journal of biological chemistry.

[12]  R. DeFronzo,et al.  Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.

[13]  S. Bonner-Weir,et al.  Prognostically Significant Heterogeneity of Cytoplasmic Islet Cell Antibodies in Relatives of Patients with Type I Diabetes , 1992, Diabetes.

[14]  E. Kraegen,et al.  Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. , 1990, The American journal of physiology.

[15]  S. Suzuki,et al.  A putative second messenger of insulin action regulates hepatic microsomal glucose-6-phosphatase. , 1984, Biochemical and biophysical research communications.

[16]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[17]  R. Nordlie,et al.  Multifunctional Glucose-6-Phosphatase: A Critical Review , 1985 .

[18]  R. Nordlie,et al.  LIVER MICROSOMAL GLUCOSE 6-PHOSPHATASE, INORGANIC PYROPHOSPHATASE, AND PYROPHOSPHATE-GLUCOSE PHOSPHOTRANSFERASE. 3. ASSOCIATED NUCLEOSIDE TRIPHOSPHATE- AND NUCLEOSIDE DIPHOSPHATE-GLUCOSE PHOSPHOTRANSFERASE ACTIVITIES. , 1965, The Journal of biological chemistry.

[19]  W. Scherbaum,et al.  Baculovirus-mediated expression of human 65 kDa and 67 kDa glutamic acid decarboxylases in SF9 insect cells and their relevance in diagnosis of insulin-dependent diabetes mellitus. , 1993, Journal of biochemistry.

[20]  R. DeFronzo,et al.  Effect of dietary protein on in vivo insulin action and liver glycogen repletion. , 1989, The American journal of physiology.

[21]  G. Shulman,et al.  Quantitative analysis of glycogen repletion by nuclear magnetic resonance spectroscopy in the conscious rat. , 1987, The Journal of clinical investigation.

[22]  K. Jungermann,et al.  Hepatocyte heterogeneity in the metabolism of carbohydrates. , 1992, Enzyme.

[23]  David E. Misek,et al.  An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl-phosphatidylinositol mimics some of the metabolic actions of insulin. , 1992, The Journal of biological chemistry.

[24]  R. Shulman,et al.  Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy. , 1985, The Journal of clinical investigation.

[25]  M. Speth,et al.  Hormone-induced effects on the rat liver microsomal glucose-6-phosphatase system in vitro. , 1981, Biochemical and biophysical research communications.

[26]  K.,et al.  Experimental validation of measurements of glucose turnover in nonsteady state. , 1978, The American journal of physiology.

[27]  R. Steele,et al.  EFFECTS OF INSULIN ON LIVER GLYCOGEN SYNTHESIS AND BREAKDOWN IN THE DOG. , 1965, The American journal of physiology.

[28]  G. Eisenbarth,et al.  Binding of Cytoplasmic Islet Cell Antibodies Is Blocked by Human Pancreatic Glycolipid Extracts , 1988, Diabetes.

[29]  M. Karnovsky,et al.  Glucose-6-phosphatase from cerebrum. , 1982, Methods in enzymology.

[30]  A. Lange,et al.  The specificity of glucose 6-phosphatase of intact liver microsomes. , 1972, The Journal of biological chemistry.

[31]  H. Lodish,et al.  Molecular Physiology of Glucose Transporters , 1990, Diabetes Care.

[32]  B. Ames ASSAY OF INORGANIC PHOSPHATE, TOTAL PHOSPHATE AND PHOSPHATASE , 1966 .

[33]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[34]  C. Newgard,et al.  Efficient hepatic glycogen synthesis in refeeding rats requires continued carbon flow through the gluconeogenic pathway. , 1984, The Journal of biological chemistry.

[35]  F. Nuttall,et al.  Liver glycogen synthase and phosphorylase changes in vivo with hypoxia and anesthetics. , 1982, The American journal of physiology.

[36]  C. Newgard,et al.  Evidence for Suppression of Hepatic Glucose-6-Phosphatase with Carbohydrate Feeding , 1984, Diabetes.

[37]  A. Tobin,et al.  Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. , 1993, The Journal of clinical investigation.

[38]  G. Shulman,et al.  Sources of carbon for hepatic glycogen synthesis in the conscious dog. , 1991, The Journal of clinical investigation.

[39]  C. Houser,et al.  Two Forms of the γ‐Aminobutyric Acid Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal Distributions and Cofactor Interactions , 1991, Journal of neurochemistry.

[40]  Brady Ro,et al.  The distribution of glutamic decarboxylase in the nervous system of the rhesus monkey. , 1959 .

[41]  A. B. Hastings,et al.  THE EFFECT OF DIABETES AND FASTING ON LIVER GLUCOSE-6-PHOSPHATASE. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Jeanrenaud,et al.  Synthase activation is not a prerequisite for glycogen synthesis in the starved liver. , 1984, The American journal of physiology.

[43]  W. Scherbaum,et al.  Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Adler,et al.  Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Cobelli,et al.  Constant specific activity input allows reconstruction of endogenous glucose concentration in non-steady state. , 1990, The American journal of physiology.

[46]  O. Walaas,et al.  Effect of epinephrine on rat diaphragm. , 1950, The Journal of biological chemistry.

[47]  R. Sherwin,et al.  Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. , 1978, The Journal of clinical endocrinology and metabolism.

[48]  G. Eisenbarth,et al.  “Cytoplasmic” Islet Cell Antibodies: Evidence That the Target Antigen Is a Sialoglycoconjugate , 1985, Diabetes.